IL9 and psoriasis: We found that injecting anti-IL-9 antibody into K5.hTGF-β1 transgenic mice not only diminished the psoriasis-like morphological changes, including cellular infiltration and neo-vascularization of the skin, but also reduced expression of IL-17A (Figure 5).